A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

Affiliation auteurs!!!! Error affiliation !!!!
TitreA phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
Type de publicationJournal Article
Year of Publication2019
AuteursGalot R., Le Tourneau C., Saada-Bouzid E., Daste A., Even C., Debruyne P.R, Henry S., Zanetta S., Rutten A., Licitra L.F, Canon J-L., Kaminsky-Forrett M-C., Specenier P., Rottey S., Dirix L., Raveloarivahy T., C. Lefevre F, Vanlancker M.BM, Govaerts A-S., Machiels J-P.
JournalANNALS OF ONCOLOGY
Volume30
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534